August 2021 (v1)
Journal article
Background: Primary inflammatory breast cancer (IBC) is a rare and aggressive entity whose prognosis has been improved by multimodal therapy. However, 5-year overall survival (OS) remains poor. Given its low incidence, the prognosis of IBC at metastatic stage is poorly described.Materials and methods: This study aimed to compare OS calculated...
Uploaded on: October 11, 2023